Shares of Nurix Therapeutics are up 3.65% or 37c to 10.50 per shares in after hours trading on Thursday after reporting quarterly results ahead of analyst estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NRIX:
- Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
- Nurix Therapeutics management to meet with Piper Sandler
- Nurix Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference
- Nurix Therapeutics, Inc. (NRIX) Q1 Earnings Cheat Sheet
- Oppenheimer reiterates Outperform on Nurix Therapeutics following Gilead news